Other Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2022

Disclosure of detailed information about intangible assets [abstract]

Summary of Carrying Amounts of Each Class of Other Intangible Assets

	KV1.3 compound			VDA compound			MultiCore technology			Cancer stem cell technology			Total
	A$			A$			A$			A$			A$
Gross carrying amount at July 1, 2020		1,546,542			2,282,527			1,265,590			19,210,485			24,305,144
Additions		-			-			-			-			-
Foreign currency exchange differences		-			-			-			(1,529,124	)		(1,529,124	)
Gross carrying amount at June 30, 2021		1,546,542			2,282,527			1,265,590			17,681,361			22,776,020
Additions		-			-			-			-			-
Foreign currency exchange differences		-			-			-			1,515,296			1,515,296
Gross carrying amount at June 30, 2022		1,546,542			2,282,527			1,265,590			19,196,657			24,291,316
Accumulated amortisation amount at July 1, 2020		(1,546,542	)		(2,282,527	)		(1,265,590	)		(7,444,073	)		(12,538,732	)
Amortisation (a)		-			-			-			(892,512	)		(892,512	)
Foreign currency exchange differences		-			-			-			600,979			600,979
Accumulated amortisation amount at June 30, 2021		(1,546,542	)		(2,282,527	)		(1,265,590	)		(7,735,606	)		(12,830,265	)
Amortisation (a)		-			-			-			(913,373	)		(913,373	)
Foreign currency exchange differences		-			-			-			(709,404	)		(709,404	)
Accumulated amortisation amount at June 30, 2022		(1,546,542	)		(2,282,527	)		(1,265,590	)		(9,358,383	)		(14,453,042	)
Net carrying amount June 30, 2021		-			-			-			9,945,755			9,945,755
Net carrying amount June 30, 2022		-			-			-			9,838,274			9,838,274

a)Depreciation is disclosed in the Consolidated Statement of Profit or Loss and Other Comprehensive Income as follows:

	2022 A$		2021 A$		2020 A$
Continuing operations		913,373		892,512		1,328,244
Discontinued operations		-		-		45,627
		913,373		892,512		1,373,871